Abstract:The gold standard for treating peripheral nerve injuries that have large nerve gaps where the nerves cannot be directly sutured back together because it creates tension on the nerve, is to incorporate an autologous nerve graft. However, even with the incorporation of a nerve graft, generally patients only regain a small portion of function in limbs affected by the injury. Although, there has been some promising results using growth factors to induce more axon growth through the nerve graft, many of these previous therapies are limited in their ability to release growth factors in a sustained manner and tailor them to a desired time frame. The ideal drug delivery platform would deliver growth factors at therapeutic levels for enough time to grow axons the entire length of the nerve graft. We hypothesized that mineral coated microparticles (MCMs) would bind, stabilize and release biologically active glial cell-derived neurotrophic factor (GDNF) and nerve growth factor (NGF) in a sustained manner. Therefore, the objective of this study was to test the ability of MCMs releasing growth factors at the distal end of a 10 mm sciatic nerve graft, to induce axon growth through the nerve graft and restore hind limb function. After sciatic nerve grafting in Lewis rats, the hind limb function was tested weekly by measuring the angle of the ankle at toe lift-off while walking down a track. Twelve weeks after grafting, the grafts were harvested and myelinated axons were analyzed proximal to the graft, in the center of the graft, and distal to the graft. Under physiological conditions <i>in vitro</i>, the MCMs delivered a burst release of NGF and GDNF for 3 days followed by a sustained release for at least 22 days. <i>In vivo</i>, MCMs releasing NGF and GDNF at the distal end of sciatic nerve grafts resulted in significantly more myelinated axons extending distal to the graft when compared to rats that received nerve grafts without growth factor treatment. The rats with nerve grafts incorporated with MCMs releasing NGF and GDNF also showed significant improvement in hind limb function starting at 7 weeks postoperatively and continuing through 12 weeks postoperatively when compared to rats that received nerve grafts without growth factor treatment. In conclusion, MCMs released biologically active NGF and GDNF in a sustained manner, which significantly enhanced axon growth resulting in a significant improvement of hind limb function in rats. The animal experiments were approved by University of Wisconsin-Madison Animal Care and Use Committee (ACUC, protocol# M5958) on January 3, 2018.

Accelerating axonal growth promotes motor recovery after peripheral nerve injury in mice

Heat shock protein is a key therapeutic target for nerve repair in autoimmune peripheral neuropathy and severe peripheral nerve injury

Human Muscle Progenitor Cells Overexpressing Neurotrophic Factors Improve Neuronal Regeneration in a Sciatic Nerve Injury Mouse Model

BDNF Promotes the Axonal Regrowth after Sciatic Nerve Crush Through Intrinsic Neuronal Capability Upregulation and Distal Portion Protection.

Axonal Regeneration: Underlying Molecular Mechanisms and Potential Therapeutic Targets

Motor Function Recovery During Peripheral Nerve Multiple Regeneration

Neural circuit repair after central nervous system injury

Brief Electrical Stimulation Promotes Recovery after Surgical Repair of Injured Peripheral Nerves

Functional recovery after peripheral nerve injury via sustained growth factor delivery from mineral-coated microparticles

Pathways regulating modality-specific axonal regeneration in peripheral nerve

Remodeling of neuromuscular junctions in target muscle following nerve regeneration in mice after delayed peripheral nerve repair

Restoring Cellular Energetics Promotes Axonal Regeneration and Functional Recovery after Spinal Cord Injury

Proportions of four distinct classes of sensory neurons are retained even when axon regeneration is enhanced following peripheral nerve injury

Selective regeneration of rat femoral nerve after crush injury and freeze injury

Specificity of Motor Axon Regeneration: A Comparison of Recovery Following Biodegradable Conduit Small Gap Tubulization and Epineurial Neurorrhaphy

(HSP40) Enhances Axon Regeneration in the Mouse Optic Nerve

Using the Neuromuscular Junction Cellular Response to Predict Functional Recovery after Nerve Grafting in a Mouse Experimental Model

Axonal regeneration stimulated by the combination of nerve growth factor and ciliary neurotrophic factor in an end-to-side model.

GABA and glycine synaptic release on axotomized motoneuron cell bodies promotes motor axon regeneration

HSP27 is Markedly Induced in Schwann Cell Columns and Associated Regenerating Axons.

Single Injection of a Novel Nerve Growth Factor Coacervate Improves Structural and Functional Regeneration after Sciatic Nerve Injury in Adult Rats.